XML 30 R18.htm IDEA: XBRL DOCUMENT v3.23.2
Earnings Per Share
 9 Months Ended
Jun. 30, 2023
Earnings Per Share [Abstract]  
Earnings Per Share EARNINGS PER SHARE:Basic earnings per share is computed using the weighted average number of common shares outstanding during the periods presented. Diluted earnings per share is computed using the weighted average number of common shares outstanding adjusted to include the potentially dilutive effect of stock awards.
The following table sets forth the computation of basic and diluted earnings per share attributable to the Company's stockholders (in thousands, except per share data):
Three Months EndedNine Months Ended
June 30, 2023July 1, 2022June 30, 2023July 1, 2022
Earnings:
Net income attributable to Aramark stockholders$338,484 $40,329 $468,676 $118,688 
Shares:
Basic weighted-average shares outstanding
260,922 257,564 260,349 257,044 
Effect of dilutive securities1,825 1,655 1,918 1,638 
Diluted weighted-average shares outstanding
262,747 259,219 262,267 258,682 
Basic Earnings Per Share:
Net income attributable to Aramark stockholders$1.30 $0.16 $1.80 $0.46 
Diluted Earnings Per Share:
Net income attributable to Aramark stockholders$1.29 $0.16 $1.79 $0.46 
Share-based awards to purchase 8.7 million and 10.0 million shares were outstanding for the three months ended June 30, 2023 and July 1, 2022, respectively, but were not included in the computation of diluted earnings per common share, as their effect would have been antidilutive. In addition, PSUs related to 0.9 million and 1.0 million shares were outstanding for the three months ended June 30, 2023 and July 1, 2022, respectively, but were not included in the computation of diluted earnings per common share, as the performance targets were not yet met.
Share-based awards to purchase 8.8 million and 9.3 million shares were outstanding for the nine months ended June 30, 2023 and July 1, 2022, respectively, but were not included in the computation of diluted earnings per common share, as their effect would have been antidilutive. In addition, PSUs related to 0.9 million and 1.0 million shares were outstanding for the nine months ended June 30, 2023 and July 1, 2022, respectively, but were not included in the computation of diluted earnings per common share, as the performance targets were not yet met.